CRESTLINE MANAGEMENT, LP – Syndax Pharmaceuticals, Inc. Transaction History
CRESTLINE MANAGEMENT, LP portfolio value:
$1.52M
portfolio value
CRESTLINE MANAGEMENT, LP quarter portfolio value change:
+24.90%
quarter
Syndax Pharmaceuticals, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | +4.95% | 3K shares | 362K | $24.03 | 63.55K |
| Q2 2022 | share | Decrease | -4.67% | -2.96K shares | 61K | $19.24 | 60.55K |
| Q1 2022 | share | Increase | 0.00% | 63.51K shares | 1.10M | $17.38 | 63.51K |
| Q3 2018 | share | Decrease | -100.00% | -35.02K shares | -246K | $8.08 | 0 |
| Q2 2018 | share | Decrease | -4.59% | -1.68K shares | -276K | $7.02 | 35.02K |
| Q1 2018 | share | Decrease | -55.84% | -46.42K shares | -206K | $14.23 | 36.71K |
| Q4 2017 | share | Increase | +55.31% | 29.60K shares | 102K | $8.76 | 83.13K |
| Q3 2017 | share | Decrease | -3.32% | -1.83K shares | -147K | $11.7 | 53.53K |
| Q2 2017 | share | Increase | 0.00% | 55.36K shares | 773K | $13.97 | 55.36K |